» Authors » A Kosch

A Kosch

Explore the profile of A Kosch including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 11
Citations 155
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nowak-Gottl U, Escuriola C, Kurnik K, Schobess R, Horneff S, Kosch A, et al.
Hamostaseologie . 2003 Feb; 23(1):36-40. PMID: 12567198
Unlabelled: For the study presented here 135 pediatric PUP patients with haemophilia consecutively admitted to German pediatric haemophilia treatment centers were investigated. In addition to factor VIII activity, the factor...
2.
von Kries R, Junker R, Oberle D, Kosch A, Nowak-Gottl U
Thromb Haemost . 2001 Nov; 86(4):1012-6. PMID: 11686317
Placental infarction is frequently observed in low birth weight children. To evaluate whether low birth weight in healthy term neonates is associated with foetal inherited prothrombotic risk factors this retrospective...
3.
Nowak-Gottl U, Kosch A, Schlegel N
Thromb Haemost . 2001 Aug; 86(1):464-74. PMID: 11487037
As in adults, acquired and inherited prothrombotic risk factors increase the risk of thrombosis in neonates, infants and children. Duplex sonography, venography, computed tomography and magnetic resonance imaging can be...
4.
Junker R, Kotthoff S, Vielhaber H, Halimeh S, Kosch A, Koch H, et al.
Cardiovasc Res . 2001 Jul; 51(2):251-4. PMID: 11470464
Objective: Recently, an association between the homozygous C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene in infants with congenital neural tube defects or congenital oral clefts has been shown. However,...
5.
Nowak-Gottl U, Strater R, Kosch A, von Eckardstein A, Schobess R, Luigs P, et al.
Eur J Haematol . 2001 Feb; 66(1):57-62. PMID: 11168509
Objectives: To investigate the relationship between an insertion/deletion (4G/5G) polymorphism of the plasminogen activator inhibitor (PAI)-1 gene and childhood patients with a past history of ischemic stroke. Methods: The PAI-1...
6.
Nowak-Gottl U, Junker R, Kreuz W, von Eckardstein A, Kosch A, Nohe N, et al.
Blood . 2001 Feb; 97(4):858-62. PMID: 11159508
After a first episode of spontaneous venous thromboembolism (VTE), the risk of recurrence persists for many years. However, comprehensive data about the risk of recurrence in pediatric patients have hitherto...
7.
Gunther G, Junker R, Strater R, Schobess R, Kurnik K, Heller C, et al.
Stroke . 2000 Oct; 31(10):2437-41. PMID: 11022077
Background And Purpose: The present multicenter case-control study was prospectively designed to assess the extent to which single and combined clotting factor abnormalities influence the onset of symptomatic ischemic stroke...
8.
Kosch A, Junker R, Kurnik K, Schobess R, Gunther G, Koch H, et al.
Thromb Res . 2000 Sep; 99(6):531-7. PMID: 10974337
The present study was designed to assess to what extent single and combined clotting abnormalities influence spontaneous vascular accidents in pediatric patients, and how the children affected differ in their...
9.
Munchow N, Kosch A, Schobess R, Junker R, Auberger K, Nowak-Gottl U
Eur J Pediatr . 2000 Jan; 158 Suppl 3:S109-12. PMID: 10650847
Unlabelled: Childhood caval vein thrombosis has a high incidence especially in the first year of life. Besides deficiencies of protein C, protein S, antithrombin and plasminogen, the factor (F) V...
10.
Kosch A, Kehrel B, Nowak-Gottl U, Haberle J, Jurgens H
Klin Padiatr . 1999 Sep; 211(4):198-200. PMID: 10472549
Background: The synthetic vasopressin derivate desmopressin (1-desamino-8-D-arginine vasopressin) has been reported to shorten the bleeding time in patients with hemophilia A, von Willebrand's disease and several functional platelet disorders. In...